Hemophilia A With Inhibitors Completed Phase 3 Trials for Vatreptacog alfa (DB12409)

Also known as: Hemophilia A With Inhibitor / Haemophilia A With Inhibitors

IndicationStatusPhase
DBCOND0032571 (Hemophilia A With Inhibitors)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01392547Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsTreatment